FOLFIRINOX-话题@MedSci

#FOLFIRINOX#

10篇内容 | 940人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1346876, encodeId=4e7f13468e646, content=<a href='/topic/show?id=f3bee569a8' target=_blank style='color:#2F92EE;'>#FOLFIRINOX#</a>, objectTitle=JAMA Oncol：术后采用改良的FOLFIRINOX方案辅助治疗可显著延长胰腺导管腺癌患者的长期预后, objectType=article, longId=738555, objectId=c150e3855510, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c150e3855510, replyNumber=0, likeNumber=42, createdTime=2022-09-09, rootId=0, userName=wjcjjian, userId=0b7c20, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c150e3855510, moduleTitle=JAMA Oncol：术后采用改良的FOLFIRINOX方案辅助治疗可显著延长胰腺导管腺癌患者的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c150e3855510)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1346875, encodeId=c53f13468e5e3, content=<a href='/topic/show?id=f3bee569a8' target=_blank style='color:#2F92EE;'>#FOLFIRINOX#</a>, objectTitle=Ther Adv Med Oncol：在FOLFIRINOX治疗失败的晚期胰腺癌患者中，GnP（吉西他滨+白蛋白结合型紫杉醇）是可行的治疗措施, objectType=article, longId=293056, objectId=308a29305649, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=308a29305649, replyNumber=0, likeNumber=35, createdTime=2021-12-30, rootId=0, userName=wjcjjian, userId=0b7c20, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=308a29305649, moduleTitle=Ther Adv Med Oncol：在FOLFIRINOX治疗失败的晚期胰腺癌患者中，GnP（吉西他滨+白蛋白结合型紫杉醇）是可行的治疗措施, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=308a29305649)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1346874, encodeId=8ed313468e4e2, content=<a href='/topic/show?id=f3bee569a8' target=_blank style='color:#2F92EE;'>#FOLFIRINOX#</a>, objectTitle=ESMO Open：Nab-紫杉醇/吉西他滨和FOLFIRINOX作为一线序贯治疗转移性胰腺癌, objectType=article, longId=221332, objectId=bde422133214, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bde422133214, replyNumber=0, likeNumber=45, createdTime=2021-12-01, rootId=0, userName=wjcjjian, userId=0b7c20, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bde422133214, moduleTitle=ESMO Open：Nab-紫杉醇/吉西他滨和FOLFIRINOX作为一线序贯治疗转移性胰腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bde422133214)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1346873, encodeId=51ea13468e3c6, content=<a href='/topic/show?id=f3bee569a8' target=_blank style='color:#2F92EE;'>#FOLFIRINOX#</a>, objectTitle=Eur J Cancer：3期| 改良版FOLFIRINOX vs S-1方案二线治疗吉西他滨难治性转移性胰腺癌的疗效, objectType=article, longId=216768, objectId=ddae216e6887, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddae216e6887, replyNumber=0, likeNumber=46, createdTime=2021-09-08, rootId=0, userName=wjcjjian, userId=0b7c20, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddae216e6887, moduleTitle=Eur J Cancer：3期| 改良版FOLFIRINOX vs S-1方案二线治疗吉西他滨难治性转移性胰腺癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddae216e6887)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1346872, encodeId=9bd413468e218, content=<a href='/topic/show?id=f3bee569a8' target=_blank style='color:#2F92EE;'>#FOLFIRINOX#</a>, objectTitle=Eur J Cancer：吉西他滨+白蛋白结合型紫杉醇对比FOLFIRINOX一线治疗晚期胰腺癌疗效和安全性, objectType=article, longId=211073, objectId=73fa2110e321, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73fa2110e321, replyNumber=0, likeNumber=59, createdTime=2021-05-12, rootId=0, userName=wjcjjian, userId=0b7c20, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73fa2110e321, moduleTitle=Eur J Cancer：吉西他滨+白蛋白结合型紫杉醇对比FOLFIRINOX一线治疗晚期胰腺癌疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73fa2110e321)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1346871, encodeId=cb5513468e100, content=<a href='/topic/show?id=f3bee569a8' target=_blank style='color:#2F92EE;'>#FOLFIRINOX#</a>, objectTitle=Lancet Gastroenterol Hepatol：晚期胰腺癌的术前诱导化疗 Nab-紫杉醇+吉西他滨是否需继以FOLFIRINOX序贯化疗？, objectType=article, longId=204661, objectId=1ee920466151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ee920466151, replyNumber=0, likeNumber=33, createdTime=2020-12-20, rootId=0, userName=wjcjjian, userId=0b7c20, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ee920466151, moduleTitle=Lancet Gastroenterol Hepatol：晚期胰腺癌的术前诱导化疗 Nab-紫杉醇+吉西他滨是否需继以FOLFIRINOX序贯化疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ee920466151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1346870, encodeId=f65713468e0e9, content=<a href='/topic/show?id=f3bee569a8' target=_blank style='color:#2F92EE;'>#FOLFIRINOX#</a>, objectTitle=JAMA Surg：FOLFIRINOX或GA方案一线治疗局限性胰腺导管腺癌, objectType=article, longId=197882, objectId=db4319e88233, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db4319e88233, replyNumber=0, likeNumber=22, createdTime=2020-07-23, rootId=0, userName=wjcjjian, userId=0b7c20, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db4319e88233, moduleTitle=JAMA Surg：FOLFIRINOX或GA方案一线治疗局限性胰腺导管腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db4319e88233)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1346869, encodeId=d9c91346869cf, content=<a href='/topic/show?id=f3bee569a8' target=_blank style='color:#2F92EE;'>#FOLFIRINOX#</a>, objectTitle=NEJM：胰腺癌辅助治疗：FOLFIRINOX方案pk吉西他滨, objectType=article, longId=158718, objectId=d507158e1853, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d507158e1853, replyNumber=0, likeNumber=37, createdTime=2019-01-25, rootId=0, userName=wjcjjian, userId=0b7c20, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d507158e1853, moduleTitle=NEJM：胰腺癌辅助治疗：FOLFIRINOX方案pk吉西他滨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d507158e1853)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1346868, encodeId=a771134686898, content=<a href='/topic/show?id=f3bee569a8' target=_blank style='color:#2F92EE;'>#FOLFIRINOX#</a>, objectTitle=CLIN CANCER RES：DNA损伤修复基因突变与接受FOLFIRINOX治疗的胰腺导管癌患者预后改善有关, objectType=article, longId=156364, objectId=7f2a1563646d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f2a1563646d, replyNumber=0, likeNumber=29, createdTime=2018-12-23, rootId=0, userName=wjcjjian, userId=0b7c20, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f2a1563646d, moduleTitle=CLIN CANCER RES：DNA损伤修复基因突变与接受FOLFIRINOX治疗的胰腺导管癌患者预后改善有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f2a1563646d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1346867, encodeId=7be1134686e8b, content=<a href='/topic/show?id=f3bee569a8' target=_blank style='color:#2F92EE;'>#FOLFIRINOX#</a>, objectTitle=Annals of Surgery：胰腺癌患者可考虑Folfirinox化疗方案, objectType=article, longId=77283, objectId=2ff7e72839d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ff7e72839d, replyNumber=0, likeNumber=35, createdTime=2016-09-14, rootId=0, userName=wjcjjian, userId=0b7c20, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ff7e72839d, moduleTitle=Annals of Surgery：胰腺癌患者可考虑Folfirinox化疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ff7e72839d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

FOLFIRINOX

2020-05-29

wjcjjian (审核中...)

前往app查看评论内容

#FOLFIRINOX#

JAMA Oncol：术后采用改良的FOLFIRINOX方案辅助治疗可显著延长胰腺导管腺癌患者的长期预后

2022-09-09

wjcjjian (审核中...)

前往app查看评论内容

#FOLFIRINOX#

Ther Adv Med Oncol：在FOLFIRINOX治疗失败的晚期胰腺癌患者中，GnP（吉西他滨+白蛋白结合型紫杉醇）是可行的治疗措施

2021-12-30

wjcjjian (审核中...)

前往app查看评论内容

#FOLFIRINOX#

ESMO Open：Nab-紫杉醇/吉西他滨和FOLFIRINOX作为一线序贯治疗转移性胰腺癌

2021-12-01

wjcjjian (审核中...)

前往app查看评论内容

#FOLFIRINOX#

Eur J Cancer：3期| 改良版FOLFIRINOX vs S-1方案二线治疗吉西他滨难治性转移性胰腺癌的疗效

2021-09-08

wjcjjian (审核中...)

前往app查看评论内容

#FOLFIRINOX#

Eur J Cancer：吉西他滨+白蛋白结合型紫杉醇对比FOLFIRINOX一线治疗晚期胰腺癌疗效和安全性

2021-05-12

wjcjjian (审核中...)

前往app查看评论内容

#FOLFIRINOX#

Lancet Gastroenterol Hepatol：晚期胰腺癌的术前诱导化疗 Nab-紫杉醇+吉西他滨是否需继以FOLFIRINOX序贯化疗？

2020-12-20

wjcjjian (审核中...)

前往app查看评论内容

#FOLFIRINOX#

JAMA Surg：FOLFIRINOX或GA方案一线治疗局限性胰腺导管腺癌

2020-07-23

wjcjjian (审核中...)

前往app查看评论内容

#FOLFIRINOX#

NEJM：胰腺癌辅助治疗：FOLFIRINOX方案pk吉西他滨

2019-01-25

wjcjjian (审核中...)

前往app查看评论内容

#FOLFIRINOX#

CLIN CANCER RES：DNA损伤修复基因突变与接受FOLFIRINOX治疗的胰腺导管癌患者预后改善有关

2018-12-23

wjcjjian (审核中...)

前往app查看评论内容

#FOLFIRINOX#

Annals of Surgery：胰腺癌患者可考虑Folfirinox化疗方案

2016-09-14

科室
- - 订阅+
  - 更多科室
工具
服务